Portfolio company Biomage, a single-cell RNA-seq analysis software maker, was acquired by Parse Biosciences.
Biomage hosts a community instance of Cellenics®, an open-source analytics tool for single-cell RNA sequencing data, developed at Harvard Medical School
Biomage hosts a community instance of Cellenics®, an open-source analytics tool for single-cell RNA sequencing data, developed at Harvard Medical School. It enables biologists to analyze single-cell datasets without coding, providing a user-friendly, cloud-based platform for data analysis.